File Download
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1002/hep.24666
- Scopus: eid_2-s2.0-80054030408
- Find via
Supplementary
-
Citations:
- Scopus: 0
- Appears in Collections:
Conference Paper: Long-term outcome of lamivudine mono-prophylaxis after liver transplantation in Hepatitis B patients
Title | Long-term outcome of lamivudine mono-prophylaxis after liver transplantation in Hepatitis B patients |
---|---|
Authors | |
Keywords | Medical sciences Gastroenterology |
Issue Date | 2011 |
Publisher | John Wiley & Sons, Inc. The Journal's web site is located at http://www.hepatology.org/ |
Citation | The 62nd Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) - The Liver Meeting 2011, San Francisco, CA., 4-8 November 2011. In Hepatology, 2011, v. 54 suppl. 1, p. 450A, abstract no. 181 How to Cite? |
Abstract | BACKGROUND/AIM: There is increasing evidence for using lower doses of hepatitis B immune globulin (HBIG) and lamivudine after liver transplantation for hepatitis B. Recent studies have demonstrated that HBIG-free regimen is effective. We report the long-term efficacy of lamivudine monotherapy in a large cohort of hepatitis B patients after liver transplantation ... |
Description | This journal suppl. contain abstracts of the 62nd Annual Meeting of the American Association for the Study of Liver Diseases: The Liver Meeting 2011 |
Persistent Identifier | http://hdl.handle.net/10722/165463 |
ISSN | 2023 Impact Factor: 12.9 2023 SCImago Journal Rankings: 5.011 |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Fung, J | en_US |
dc.contributor.author | Chan, SC | en_US |
dc.contributor.author | Yuen, MF | en_US |
dc.contributor.author | Lai, CL | en_US |
dc.contributor.author | Chok, KSH | en_US |
dc.contributor.author | Sharr, W | en_US |
dc.contributor.author | Dai, WC | en_US |
dc.contributor.author | Fan, ST | en_US |
dc.contributor.author | Lo, CM | en_US |
dc.date.accessioned | 2012-09-20T08:18:24Z | - |
dc.date.available | 2012-09-20T08:18:24Z | - |
dc.date.issued | 2011 | en_US |
dc.identifier.citation | The 62nd Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) - The Liver Meeting 2011, San Francisco, CA., 4-8 November 2011. In Hepatology, 2011, v. 54 suppl. 1, p. 450A, abstract no. 181 | en_US |
dc.identifier.issn | 0270-9139 | - |
dc.identifier.uri | http://hdl.handle.net/10722/165463 | - |
dc.description | This journal suppl. contain abstracts of the 62nd Annual Meeting of the American Association for the Study of Liver Diseases: The Liver Meeting 2011 | - |
dc.description.abstract | BACKGROUND/AIM: There is increasing evidence for using lower doses of hepatitis B immune globulin (HBIG) and lamivudine after liver transplantation for hepatitis B. Recent studies have demonstrated that HBIG-free regimen is effective. We report the long-term efficacy of lamivudine monotherapy in a large cohort of hepatitis B patients after liver transplantation ... | - |
dc.language | eng | en_US |
dc.publisher | John Wiley & Sons, Inc. The Journal's web site is located at http://www.hepatology.org/ | - |
dc.relation.ispartof | Hepatology | en_US |
dc.rights | Hepatology. Copyright © John Wiley & Sons, Inc. | - |
dc.subject | Medical sciences | - |
dc.subject | Gastroenterology | - |
dc.title | Long-term outcome of lamivudine mono-prophylaxis after liver transplantation in Hepatitis B patients | en_US |
dc.type | Conference_Paper | en_US |
dc.identifier.email | Fung, J: jfung@hkucc.hku.hk | en_US |
dc.identifier.email | Chan, SC: chanlsc@hkucc.hku.hk | en_US |
dc.identifier.email | Yuen, MF: mfyuen@hku.hk | en_US |
dc.identifier.email | Lai, CL: hrmelcl@hku.hk | en_US |
dc.identifier.email | Fan, ST: stfan@hku.hk | en_US |
dc.identifier.email | Lo, CM: chungmlo@hkucc.hku.hk | en_US |
dc.identifier.authority | Fung, J=rp00518 | en_US |
dc.identifier.authority | Chan, SC=rp01568 | en_US |
dc.identifier.authority | Yuen, MF=rp00479 | en_US |
dc.identifier.authority | Lai, CL=rp00314 | en_US |
dc.identifier.authority | Fan, ST=rp00355 | en_US |
dc.identifier.authority | Lo, CM=rp00412 | en_US |
dc.description.nature | link_to_OA_fulltext | - |
dc.identifier.doi | 10.1002/hep.24666 | - |
dc.identifier.scopus | eid_2-s2.0-80054030408 | - |
dc.identifier.hkuros | 211115 | en_US |
dc.identifier.volume | 54 | en_US |
dc.identifier.issue | suppl. 1 | en_US |
dc.identifier.spage | 450A, abstract no. 181 | en_US |
dc.identifier.epage | 450A, abstract no. 181 | en_US |
dc.publisher.place | United States | - |
dc.description.other | The 62nd Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), San Francisco, CA., 4-8 November 2011. In Hepatology, 2011, v. 54 suppl. 1, p. 450A-450A, abstract no. 181 | - |
dc.identifier.issnl | 0270-9139 | - |